|
Jul 15
|
Chronic Rhinosinusitis with Nasal Polyps Market Analysis and Forecast Report 2025-2035, Featuring AstraZeneca, Amgen, GlaxoSmithKline, Keymed Biosciences, Biohaven Pharmaceuticals, Sanofi, and More
|
|
Aug 27
|
Keymed Biosciences Announces Interim Results for First Half of 2024
|
|
Jun 20
|
Keymed Biosciences Announces Safety and Efficacy Results of CM313 for Primary Immune Thrombocytopenia Published in NEJM
|